Impact of Yoga As Complementary Therapy in Patients Undergoing Radical Prostatectomy
| Status: | Recruiting |
|---|---|
| Conditions: | Prostate Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 30 - 80 |
| Updated: | 12/26/2018 |
| Start Date: | September 2015 |
| End Date: | December 31, 2020 |
Impact of Yoga As Complementary Therapy on Quality of Life, Pro-inflammatory, and Cellular Immune Biomarkers in Patients Undergoing Radical Prostatectomy: A Pilot Randomized-Controlled Trial
The researchers hope to learn if yoga complementary therapy would improve health-related
quality of life, recovery of urinary continence and erectile function in patients who
underwent prostate cancer surgery (i.e. radical prostatectomy). We hypothesized that in
patients undergoing radical prostatectomy, preoperative and postoperative Yoga complementary
therapy would improve health- related quality of life (HRQOL), recovery of urinary continence
and erectile function.
This two-arm, randomized controlled pilot study will compare Yoga intervention to usual care
group. The aim is to evaluate the efficacy of Yoga complementary therapy on HRQOL in patients
who underwent radical prostatectomy (RP). Yoga therapy will be given to the intervention
group three times in a week for 6 weeks prior to surgery and then initiated 3 weeks after the
surgery for another 6 weeks. The yoga exercise will be tailored to the participant's comfort
level. As an exploratory analysis, we will evaluate pro-inflammatory and immunological
markers.
quality of life, recovery of urinary continence and erectile function in patients who
underwent prostate cancer surgery (i.e. radical prostatectomy). We hypothesized that in
patients undergoing radical prostatectomy, preoperative and postoperative Yoga complementary
therapy would improve health- related quality of life (HRQOL), recovery of urinary continence
and erectile function.
This two-arm, randomized controlled pilot study will compare Yoga intervention to usual care
group. The aim is to evaluate the efficacy of Yoga complementary therapy on HRQOL in patients
who underwent radical prostatectomy (RP). Yoga therapy will be given to the intervention
group three times in a week for 6 weeks prior to surgery and then initiated 3 weeks after the
surgery for another 6 weeks. The yoga exercise will be tailored to the participant's comfort
level. As an exploratory analysis, we will evaluate pro-inflammatory and immunological
markers.
Inclusion Criteria:
- Men between the age of 30 to 80
- Has been diagnosed with localized prostate cancer (i.e. pathologically and/or
radiographically confirmed)
- Is scheduled to undergo radical prostatectomy (i.e. robot-assisted or open-approach)
- Has no other active primary malignancy aside from prostate cancer
- Currently not practicing yoga as a form of exercise and/or meditation
- Does not have uncontrolled pain
- Does not have neurological or musculoskeletal co-morbidity inhibiting exercise
- Has never been diagnosed by health care professionals to have absolute
contraindications to exercise testing
- Willing to be randomized to either standard care or intervention group
- Willing to participate in yoga therapy for twelve weeks if randomized to intervention
group
- Willing to undergo phlebotomy
- Able and willing to provide informed consent
Exclusion Criteria:
- Men under the age of 30 or over the age of 80
- Has NOT been diagnosed with localized prostate cancer (i.e. pathologically and/or
radiographically confirmed)
- Is NOT scheduled to undergo radical prostatectomy (i.e. robot-assisted or
open-approach)
- Has other active primary malignancy aside from prostate cancer
- Currently practicing yoga as a form of exercise and/or meditation
- Has uncontrolled pain
- Has neurological or musculoskeletal co-morbidity inhibiting exercise
- Has been diagnosed with psychotic, addictive, and major cognitive disorders
- Has been diagnosed by health care professionals to have absolute contraindications to
exercise testing Unwilling to be randomized to either standard care or intervention
group
- Unwilling to participate in yoga therapy for twelve weeks if randomized to
intervention group
- Unwilling to undergo phlebotomy
- Unable and unwilling to provide informed consent
We found this trial at
1
site
4502 Medical Drive
San Antonio, Texas 78284
San Antonio, Texas 78284
(210) 567-7000
Principal Investigator: Dharam Kaushik, MD
Phone: 210-550-0715
University of Texas Health Science Center at San Antonio The University of Texas Health Science...
Click here to add this to my saved trials
